Diagnosis and Classification of the Schizophrenia Spectrum Disorders

More documents

Recommendations

Info

250 B. Dean et al.63. Impagnatiello F, Guidotti AR, Pesold C et al (1998) A decrease of reelin expression as aputative vulnerability factor in schizophrenia. Proc Natl Acad Sci USA 95:15718–1572364. Gibbons AS, Thomas EA, Scarr E et al (2010) Low-density lipoprotein receptor-relatedprotein and apolipoprotein E expression is altered in schizophrenia. Front Psychiatrydoi:10.3389/fpsyt.2010.0001965. Sugiyama T, Kumagai H, Morikawa Y et al (2000) A novel low-density lipoprotein receptorrelatedprotein mediating cellular uptake of apolipoprotein E-enriched beta-VLDL in vitro.Biochemistry 39:15817–1582566. Siest G, Pillot T, Regis-Bailly A et al (1995) Apolipoprotein E: an important gene and proteinto follow in laboratory medicine. Clin Chem 41:1068–108667. Dumanis SB, Tesoriero JA, Babus LW et al (2009) ApoE4 decreases spine density anddendritic complexity in cortical neurons in vivo. J Neurosci 29:15317–1532268. Brans RG, van Haren NE, van Baal GC et al (2008) Longitudinal MRI study in schizophreniapatients and their healthy siblings. Br J Psychiatry 193:422–42369. Farrow TF, Whitford TJ, Williams LM et al (2005) Diagnosis-related regional gray matter lossover two years in first episode schizophrenia and bipolar disorder. Biol Psychiatry 58:713–72370. Whitford TJ, Grieve SM, Farrow TF et al (2007) Volumetric white matter abnormalities infirst-episode schizophrenia: a longitudinal, tensor-based morphometry study. Am J Psychiatry164:1082–108971. DeLisi LE, Sakuma M, Maurizio AM et al (2004) Cerebral ventricular change over the first10 years after the onset of schizophrenia. Psychiatry Res 130:57–7072. Ho BC, Andreasen NC, Nopoulos P et al (2003) Progressive structural brain abnormalitiesand their relationship to clinical outcome: a longitudinal magnetic resonance imaging studyearly in schizophrenia. Arch Gen Psychiatry 60:585–59473. Mathalon DH, Sullivan EV, Lim KO et al (2001) Progressive brain volume changes and theclinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study.Arch Gen Psychiatry 58:148–15774. Maier M, Ron MA (1996) Hippocampal age-related changes in schizophrenia: a protonmagnetic resonance spectroscopy study. Schizophr Res 22:5–1775. Pantelis C, Velakoulis D, McGorry PD et al (2003) Neuroanatomical abnormalities beforeand after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361:281–28876. Wang L, Mamah D, Harms MP et al (2008) Progressive deformation of deep brain nuclei andhippocampal-amygdala formation in schizophrenia. Biol Psychiatry 64:1060–106877. Chakos MH, Schobel SA, Gu H et al (2005) Duration of illness and treatment effects onhippocampal volume in male patients with schizophrenia. Br J Psychiatry 186:26–3178. Sporn AL, Greenstein DK, Gogtay N et al (2003) Progressive brain volume loss duringadolescence in childhood-onset schizophrenia. Am J Psychiatry 160:2181–218979. Giedd JN, Jeffries NO, Blumenthal J et al (1999) Childhood-onset schizophrenia: progressivebrain changes during adolescence. Biol Psychiatry 46:892–89880. Salisbury DF, Kuroki N, Kasai K et al (2007) Progressive and interrelated functional andstructural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiatry64:521–52981. Meagher DJ, Quinn JF, Bourke S et al (2004) Longitudinal assessment of psychopathologicaldomains over late-stage schizophrenia in relation to duration of initially untreatedpsychosis: 3-year prospective study in a long-term inpatient population. Psychiatry Res 126:217–22782. Fornito A, Yucel M, Dean B et al (2009) Anatomical abnormalities of the anterior cingulatecortex in schizophrenia: bridging the gap between neuroimaging and neuropathology.Schizophr Bull 35:973–99383. Jaaro-Peled H, Ayhan Y, Pletnikov MV et al (2010) Review of pathological hallmarks ofschizophrenia: comparison of genetic models with patients and nongenetic models. SchizophrBull 36:301–313
10 Changes in Gene Expression 25184. Perez-Costas E, Melendez-Ferro M, Roberts RC (2010) Basal ganglia pathology inschizophrenia: dopamine connections and anomalies. J Neurochem 113:287–30285. Wang Y, Stricker HM, Gou D et al (2007) MicroRNA: past and present. Front Biosci 12:2316–232986. Dean B, Pavey G, Smith I (2008) Using differential solubilization and 2-D gel electrophoresisto visualize increased numbers of proteins in the human cortex and caudate nucleus andputamen. Proteomics – Clin Appl 2:1281–128987. Tamminga CA (2008) Accelerating new knowledge in schizophrenia. Am J Psychiatry165:949–95188. Scarr E, Cowie TF, Kanellakis S et al (2009) Decreased cortical muscarinic receptors definea subgroup of subjects with schizophrenia. Mol Psychiatry 14:1017–102389 Maheswaran S, Barjat H, Rueckert D et al (2009) Longitudinal regional brain volume changesquantified in normal aging and Alzheimer’s APP x PS1 mice using MRI. Brain Res 1270:19–3290. Scheff SW, Price DA, Sparks DL (2001) Quantitative assessment of possible age-relatedchange in synaptic numbers in the human frontal cortex. Neurobiol Aging 22:355–365
Page 2:
Handbook of Schizophrenia Spectrum
Page 5 and 6:
EditorMichael S. RitsnerTechnion -
Page 7 and 8:
viForewordpsychotic disorders, gene
Page 9 and 10:
viiiForewordItaly, Israel, Japan, S
Page 11 and 12:
xContents9 Schizophrenia Has a High
Page 13 and 14:
This is Blank Page Integraxii
Page 15 and 16:
xivContributorsBrazil; Laboratory o
Page 17 and 18:
xviContributorsLuca De Peri Departm
Page 19 and 20:
Chapter 1The Schizophrenia Construc
Page 21 and 22:
1 The Schizophrenia Construct After
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Chapter 2Diagnosis and Classificati
Page 65 and 66:
2 Diagnosis and Classification of t
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
86 M.S. RitsnerKeywords Functional
Page 105 and 106:
88 M.S. RitsnerProof-of-Concept for
Page 107 and 108:
90 M.S. RitsnerTable 3.1 Measuring
Page 109 and 110:
92 M.S. RitsnerTable 3.2 Definition
Page 111 and 112:
94 M.S. RitsnerFactor Structure: Th
Page 113 and 114:
96 M.S. RitsnerFig. 3.4 Frequency o
Page 115 and 116:
98 M.S. RitsnerPatients Sex Age(yr.
Page 117 and 118:
100 M.S. RitsnerTable 3.4 Frequency
Page 119 and 120:
102 M.S. Ritsner1. A genetic load h
Page 121 and 122:
104 M.S. Ritsnerneuronal function a
Page 123 and 124:
106 M.S. RitsnerMulti-dimensional p
Page 125 and 126:
108 M.S. Ritsner39. Fink M (2009) C
Page 127 and 128:
110 M.S. Ritsner82. Walsh T, McClel
Page 129 and 130:
112 M.S. Ritsner125. Kissling W, He
Page 131 and 132:
Chapter 4Irving Gottesman and the S
Page 133 and 134:
4 Irving Gottesman and the Schizoph
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
128 M.F. LenzenwegerKeywords Schizo
Page 145 and 146:
130 M.F. LenzenwegerReactionsSchizo
Page 147 and 148:
132 M.F. Lenzenwegerorganize resear
Page 149 and 150:
134 M.F. Lenzenwegerdone recently b
Page 151 and 152:
136 M.F. Lenzenwegerwith a “story
Page 153 and 154:
138 M.F. Lenzenwegernot be true (se
Page 155 and 156:
140 M.F. Lenzenweger3. Rado S (1960
Page 157 and 158:
Chapter 6Autistic Spectrum Disorder
Page 159 and 160:
6 Autistic Spectrum Disorders and S
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Chapter 7One Hundred Years of Insan
Page 179 and 180:
7 One Hundred Years of Insanity 165
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
188 A.R. Rădulescutreatment can be
Page 203 and 204:
190 A.R. Rădulescupathways have no
Page 205 and 206:
192 A.R. Rădulescukey functions re
Page 207 and 208:
194 A.R. Rădulescuincreasing insta
Page 209 and 210:
196 A.R. Rădulescucorrections of t
Page 211 and 212: 198 A.R. RădulescuQuantifying Schi
Page 213 and 214: 200 A.R. RădulescuTable 8.1 Profil
Page 215 and 216: 202 A.R. RădulescuFig. 8.4 Princip
Page 217 and 218: 204 A.R. RădulescuFig. 8.5 Charact
Page 219 and 220: 206 A.R. Rădulescuto use discrete
Page 221 and 222: 208 A.R. RădulescuAppendix 1: Simp
Page 223 and 224: 210 A.R. RădulescuStudy design, ta
Page 225 and 226: 212 A.R. Rădulescu35. Kitzbichler
Page 227 and 228: 214 A.R. Rădulescu83. Shibata T, T
Page 229 and 230: 216 A.R. Rădulescu132. Rosenkranz
Page 231 and 232: Chapter 9Schizophrenia Has a High H
Page 233 and 234: 9 Schizophrenia Has a High Heritabi
Page 249 and 250: Chapter 10Changes in Gene Expressio
Page 251 and 252: 10 Changes in Gene Expression 239ge
Page 253 and 254: 10 Changes in Gene Expression 241Ta
Page 255 and 256: 10 Changes in Gene Expression 243fu
Page 257 and 258: 10 Changes in Gene Expression 245ex
Page 259 and 260: 10 Changes in Gene Expression 247el
Page 261: 10 Changes in Gene Expression 24941
Page 265 and 266: 254 G.B. Baker et al.fMRIGABAGTIHPL
Page 267 and 268: 256 G.B. Baker et al.[20-26]. Glyci
Page 269 and 270: 258 G.B. Baker et al.suggesting bot
Page 271 and 272: 260 G.B. Baker et al.14. Labrie V,
Page 273 and 274: 262 G.B. Baker et al.54. Palsson E,
Page 275 and 276: 264 S.L. Bronson and N.M. RichtandA
Page 277 and 278: 266 S.L. Bronson and N.M. Richtandt
Page 279 and 280: 268 S.L. Bronson and N.M. RichtandP
Page 281 and 282: 270 S.L. Bronson and N.M. Richtandi
Page 283 and 284: 272 S.L. Bronson and N.M. RichtandB
Page 285 and 286: 274 S.L. Bronson and N.M. Richtandm
Page 287 and 288: 276 S.L. Bronson and N.M. RichtandG
Page 289 and 290: 278 S.L. Bronson and N.M. RichtandB
Page 291 and 292: 280 S.L. Bronson and N.M. Richtandp
Page 293 and 294: 282 S.L. Bronson and N.M. Richtand3
Page 295 and 296: 284 S.L. Bronson and N.M. Richtand8
Page 297 and 298: Chapter 13Glutamatergic Neurotransm
Page 299 and 300: 13 Glutamatergic Neurotransmission
Page 313 and 314:
13 Glutamatergic Neurotransmission
Page 315 and 316:
Chapter 14Mathematical Models in Sc
Page 317 and 318:
14 Mathematical Models in Schizophr
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
Page 325 and 326:
Page 327 and 328:
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Page 335 and 336:
Page 337 and 338:
328 C.A. Bousman et al.Introduction
Page 339 and 340:
330 C.A. Bousman et al.prolonged. B
Page 341 and 342:
332 C.A. Bousman et al.Biomarker Di
Page 343 and 344:
334 C.A. Bousman et al.Table 15.3 G
Page 345 and 346:
336 C.A. Bousman et al.precision th
Page 347 and 348:
338 C.A. Bousman et al.15. United N
Page 349 and 350:
340 C.A. Bousman et al.60. Ikeda M,
Page 351 and 352:
342 C.A. Bousman et al.98. Scott JC
Page 353 and 354:
Chapter 16What Does Proteomics Tell
Page 355 and 356:
16 What Does Proteomics Tell Us Abo
Page 357 and 358:
Page 359 and 360:
Page 361 and 362:
Page 363 and 364:
Page 365 and 366:
Page 367 and 368:
Page 369 and 370:
Page 371 and 372:
Page 373 and 374:
Page 375 and 376:
Chapter 17TheRoleof3α-Hydroxy-5α-
Page 377 and 378:
17 The Role of 3α-Hydroxy-5α-Preg
Page 379 and 380:
Page 381 and 382:
Page 383 and 384:
Page 385 and 386:
Page 387 and 388:
Page 389 and 390:
Page 391 and 392:
Page 393 and 394:
Page 395 and 396:
Page 397 and 398:
Page 399 and 400:
Page 401 and 402:
Page 403 and 404:
Page 405 and 406:
Page 407 and 408:
Page 409 and 410:
Page 411 and 412:
Page 413 and 414:
Chapter 18Neural Substrates of Emot
Page 415 and 416:
18 Neural Substrates of Emotion Dys
Page 417 and 418:
Page 419 and 420:
Page 421 and 422:
Page 423 and 424:
Page 425 and 426:
Page 427 and 428:
Page 429 and 430:
Page 431 and 432:
Page 433 and 434:
Page 435 and 436:
Page 437 and 438:
Page 439 and 440:
432 A. Vita et al.AbbreviationsBD B
Page 441 and 442:
434 A. Vita et al.Bipolar DisorderA
Page 443 and 444:
436 A. Vita et al.temporale, and ca
Page 445 and 446:
438 A. Vita et al.Among the many po
Page 447 and 448:
440 A. Vita et al.22. Hietala J, Ca
Page 449 and 450:
442 A. Vita et al.60. Peters BD, de
Page 451 and 452:
Chapter 20Mapping Prodromal Psychos
Page 453 and 454:
20 Mapping Prodromal Psychosis 447i
Page 455 and 456:
20 Mapping Prodromal Psychosis 449t
Page 457 and 458:
20 Mapping Prodromal Psychosis 451F
Page 459 and 460:
20 Mapping Prodromal Psychosis 453s
Page 461 and 462:
Page 463 and 464:
20 Mapping Prodromal Psychosis 457o
Page 465 and 466:
20 Mapping Prodromal Psychosis 459N
Page 467 and 468:
20 Mapping Prodromal Psychosis 461T
Page 469 and 470:
Page 471 and 472:
20 Mapping Prodromal Psychosis 465p
Page 473 and 474:
20 Mapping Prodromal Psychosis 4673
Page 475 and 476:
Page 477 and 478:
Page 479 and 480:
474 Afterwordon the current paradig
Page 481 and 482:
476 Afterwordpsychiatric disorders
Page 483 and 484:
478 Contents to Volume II10 Schizop
Page 485 and 486:
480 Contents to Volume III10 Revisi
Page 487 and 488:
482 Contributors to Volume IIRuth C
Page 489 and 490:
484 Contributors to Volume IIGary R
Page 492 and 493:
Contributors to Volume IIIAnthony O
Page 494 and 495:
Contributors to Volume III 489Jenni
Page 496 and 497:
IndexAAcute transient psychosis, 5,
Page 498 and 499:
Index 493Impairment, 7, 18, 20-22,
show all

Diagnosis and Classification of the Schizophrenia Spectrum Disorders

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?